Hypolipidemic Agents: Clinical Trials

8 trials of Hypolipidemic Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 recruiting, 1 terminated. 3 Phase 4, 2 Not applicable, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Recruiting 1
Not applicable2Completed 1, Terminated 1
Phase 21Completed 1
Phase 31Completed 1

Follow Hypolipidemic Agents: new trials by email Literature Review of Hypolipidemic Agents trials Research Report on Hypolipidemic Agents

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-inflammatory Therapy for Recurrent In-stent Restenosis
Colchicine, Prednisone, Aspirin - In-stent Restenosis
Phase 4RecruitingFu Wai Hospital, Beijing, China2522023-10-302025-08-08
Role of Fenofibrate in Neonatal Jaundice
Fenofibrate, placebo - Neonatal Jaundice
Phase 4CompletedAin Shams University752023-07-012024-06-11
Randomized Study of Obicetrapib in Combination With Ezetimibe
Obicetrapib 5mg, Ezetimibe 10mg, Placebo - Dyslipidemias, High Cholesterol
Phase 2CompletedNewAmsterdam Pharma1122021-02-232024-04-24
Consequences of Doing What Should Not be Done in Primary Care
Benzodiazepines, Non-steroidal anti-inflammatory drugs, paracetamol - Overdose, Adverse Event
CompletedUniversidad Miguel Hernandez de Elche7500002018-10-142020-04-03
Lipid-lowering Agents in Patients With Dermatomyositis and Polymyositis
Lipid-lowering agents (Artovastatin) - Treatment Side Effects
Not applicableTerminatedUniversity of Sao Paulo242017-01-012022-06-03
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Cardiovascular Polypill, Treatment Prevention for Secondary CV - Myocardial Infarction, Cardiovascular Disease
Phase 3CompletedFundación Centro Nacional de Investigaciones Cardiovasculares Carlos III24992016-07-012025-05-23
Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
Pioglitazone 15 mg Tablet, Isosorbide Dinitrate 10Mg Tablet, Acetylsalicylic Acid 75Mg Tablet - Adverse Effect, Atherosclerosis, Coronary
Phase 4CompletedUkrainian Medical Stomatological Academy432012-11-012022-03-10
Effect of Simvastatin and Ezetimibe on Lipid and Inflammation
Simvastatin, Ezetimibe, Combination Simvastatin plus Ezetimibe - Prediabetes, Hypercholesterolemia
Not applicableCompletedFederal University of São Paulo502005-06-012010-04-15

Conditions studied

Atherosclerosis (2)  ·  Hypercholesterolemia (2)  ·  Cardiovascular Diseases (1)  ·  Coronary Artery Disease (1)  ·  Coronary Disease (1)  ·  Drug Overdose (1)  ·  Dyslipidemias (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Jaundice, Neonatal (1)  ·  Metabolic Syndrome (1)  ·  Myocardial Infarction (1)  ·  Prediabetic State (1)

Sponsors

Ain Shams University (1)  ·  Federal University of São Paulo (1)  ·  Fu Wai Hospital, Beijing, China (1)  ·  Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (1)  ·  NewAmsterdam Pharma (1)  ·  Ukrainian Medical Stomatological Academy (1)  ·  Universidad Miguel Hernandez de Elche (1)  ·  University of Sao Paulo (1)

Countries

Brazil (2)  ·  Spain (2)  ·  China (1)  ·  Czechia (1)  ·  Egypt (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Ukraine (1)  ·  United States (1)

Top investigators

Haiyan Qian (1)  ·  Jose Maria Castellano Vazquez, MD, PhD (1)  ·  Samuel K Shinjo, PhD (1)  ·  Sandra RG Ferreira, PhD (1)  ·  Valentin Fuster, MD, PhD (1)

Results publications

PMID 20529243, PMID 30837247, PMID 34009877, PMID 34324628, PMID 36018037, PMID 41145262, PMID 41190670

NIH funding

2015 (1)